Latest Articles

  • An unusual cause of vitamin B12 and iron deficiency
    Shelley Maithel, BA, Alex K. Duong, Jonathan Zhang, MD and Douglas L. Nguyen, MD
    Cleveland Clinic Journal of Medicine July 2015, 82 (7) 406-408; DOI: https://doi.org/10.3949/ccjm.82a.14151

    Testing for ova and parasites was negative, but video capsule endoscopy revealed a tapeworm in the distal duodenum.

  • Urologic applications of botulinum toxin
    Ashley King, MD, Adrienne Quirouet, MD and Courtenay K. Moore, MD
    Cleveland Clinic Journal of Medicine July 2015, 82 (7) 456-464; DOI: https://doi.org/10.3949/ccjm.82a.13166

    Botulinum toxin is approved for neurogenic detrusor overactivity and overactive bladder refractory to drug therapy.

  • Care of the aging HIV patient
    Jason M. Blaylock, MD and Glenn W. Wortmann, MD
    Cleveland Clinic Journal of Medicine July 2015, 82 (7) 445-455; DOI: https://doi.org/10.3949/ccjm.82a.14094

    Today, more than 50% of all HIV-infected people in the United States are over age 50.

  • In Reply: The health care ‘iron triangle’ (February 2015)
    Elmer Philip Lehman, MD, MPP
    Cleveland Clinic Journal of Medicine June 2015, 82 (6) 334-335; DOI: https://doi.org/10.3949/ccjm.82c.06005

    Readers comment on enterovirus D-68 (January 2015), eosinophilic esophagitis (February 2015), the Patient Protection and Affordable Care Act (February 2015), and alcoholic hepatitis (March 2015).

  • ST-segment elevation: Differential diagnosis, caveats
    Elias B. Hanna, MD and David Luke Glancy, MD
    Cleveland Clinic Journal of Medicine June 2015, 82 (6) 373-384; DOI: https://doi.org/10.3949/ccjm.82a.14026

    Our first concern is myocardial infarction. However, several other conditions can also cause ST elevation.

  • Alcoholic hepatitis: An important consideration (April 2015)
    Aibek E. Mirrakhimov, MD
    Cleveland Clinic Journal of Medicine June 2015, 82 (6) 335; DOI: https://doi.org/10.3949/ccjm.82c.06006

    Readers comment on enterovirus D-68 (January 2015), eosinophilic esophagitis (February 2015), the Patient Protection and Affordable Care Act (February 2015), and alcoholic hepatitis (March 2015).

  • In Reply: Eosinophilic esophagitis (February 2015)
    David A. Katzka, MD
    Cleveland Clinic Journal of Medicine June 2015, 82 (6) 333; DOI: https://doi.org/10.3949/ccjm.82c.06003

    Readers comment on enterovirus D-68 (January 2015), eosinophilic esophagitis (February 2015), the Patient Protection and Affordable Care Act (February 2015), and alcoholic hepatitis (March 2015).

  • Enterovirus D-68 presenting with acute pancreatitis (January 2015)
    Burke A. Cunha, MD, Gina Wu, MD, Marie Dumont, CIC, Eileen Abruzzo, RN, CIC and Muhammad Raza, MBBS
    Cleveland Clinic Journal of Medicine June 2015, 82 (6) 332; DOI: https://doi.org/10.3949/ccjm.82c.06001

    Readers comment on enterovirus D-68 (January 2015), eosinophilic esophagitis (February 2015), the Patient Protection and Affordable Care Act (February 2015), and alcoholic hepatitis (March 2015).

  • Vaccination: Special populations are not all the same
    Atul Khasnis, MD
    Cleveland Clinic Journal of Medicine June 2015, 82 (6) 348-349; DOI: https://doi.org/10.3949/ccjm.82a.14137

    Guidelines exist, but so do uncertainties.

  • Corneal opacities in a man with chronic kidney disease
    Omer Ibrahim, MD, Linda Amah, MD and Sharon E. Mace, MD, FACEP, FAAP
    Cleveland Clinic Journal of Medicine June 2015, 82 (6) 339-340; DOI: https://doi.org/10.3949/ccjm.82a.14080

    Effects of lecithin-cholesterol acyltransferase deficiency include coronary artery disease, renal disease, and corneal opacity.

Pages